Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, expression, and optimization services for biotech and pharmaceutical companies.
From gene sequence to purified antibodies, our production only takes 2 weeks — and with RushData, our AI antibody wet lab validation service, computational predictions become experimentally confirmed candidates at high throughput. We have delivered tens of thousands of recombinant antibodies for more than 3,000 biotech and pharma companies worldwide.
Contact us: +1(732)790-8340, or [email protected]. Visit our website: www.biointron.com
News & Insights
From Biointron
Member Insight
September Update: Antibody Industry Trends (Q3 2026 Insights, Trends & Analysis)
Member Insight
Biointron Insights: Antibody Industry Trends (Q2 2026 Insights, Trends & Analysis)
Member News
Biointron Launches RushData, a New Integrated Platform in the Era of AI-Driven Antibody Design
Member Insight
Biointron Insights: Antibody Industry Trends (Q1 2026 Insights, Trends & Analysis)